PD

Phoolchand Dayashankar Maurya

Director Director DIN 09628884
DIN 09628884 First appointment Jun 2022 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 1 historical roles
Total affiliations 1 Since Jun 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Phoolchand Dayashankar Maurya

Data last updated:

Phoolchand Dayashankar Maurya was a Director at Chandravim Exim Private Limited (2022–2024). The company operates in Pharma.

DIN 09628884
Primary Designation Director
Industry Pharma
First Appointment 02 Jun 2022

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Chandravim Exim Private Limited U24299MH2022PTC384006
Director02 Jun 20222022₹6.81 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Chandravim Exim Private Limited
Premium access

Shareholding and investment profile for Phoolchand Dayashankar Maurya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Phoolchand Dayashankar Maurya

Phoolchand Dayashankar Maurya was first appointed on 02 Jun 2022 as Director at Chandravim Exim Private Limited.

Phoolchand Dayashankar Maurya held 1 earlier board appointment: Chandravim Exim Private Limited (Director, 02 Jun 2022 to 01 Jan 2024).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available